Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.
 
> TCC, Human, mAb aE11, FITC

TCC, Human, mAb aE11, FITC

Imprimer Imprimer
Identifiez-vous

Référence HM2167F-100UG

Conditionnement : 100ug

Marque : Hycult Biotech

Demander plus d'informations

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

TCC, Human, mAb aE11, FITC

Monoclonal antibody aE11 reacts with a C9 neoantigen of the terminal complement complex (TCC).

Monoclonal antibody aE11 reacts with a C9 neoantigen of the terminal complement complex (TCC).

The three distinct activation pathways of complement converge with the formation of a C5 convertase. The cleavage of C5 by this convertase initiates the lytic or terminal pathway. In contrast to the activation pathways, which require enzymatic cleavage for activation, the terminal pathway relies on conformational changes induced by binding. Binding of C6 facilitates binding of C7 which alters the conformation of the complex.

After binding of C8, a variable number of C9 molecules associate with the C5b678 complex, which is also termed- the terminal complement complex (TCC). The formation of TCC causes lysis of cells or can trigger a variety of cellular metabolic pathways resulting in the synthesis and release of inflammatory mediators. The TCC contains neoantigens that are absent from the individual native components.- C9 neoantigens are present both in the membrane-bound (MAC) and the fluid-phase (SC5b-9) complex. TCC is present in normal human plasma and increased in patients with complement activation.

Application
Flow cytometry, Frozen sections, Functional studies, Immuno assays, Immuno fluorescence, Paraffin sections

Application Notes
FS: Antibody aE11 inhibits platelet activation by antiphospholipid antibody serum. (Ref.5).
IF: Cryosections of 10 μm were dried, fixed in acetone at 4°C for 10 min, dried and blocked for 20 min with PBSA.

Use
Dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.

Positive Control
Mucosa from patients with H. Pylori.

Product type
Monoclonal antibodies
Amount
100 µg, 20 µg
Formulation
0.2 ml (100 μg/ml) 0.2 μm filtered protein G purified FITC conjugated antibody solution in PBS containing 1% bovine serum albumin and 0.02% sodium azide.
Conjugate
FITC
Isotype
Mouse IgG2a
Species
Human
Cross reactivity
Horse – Yes, Pig – Yes
Alias
Terminal complement complex, MAC complex, complement membrane attack complex, sC5b-9 complex.
Storage and stability
Product should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
Precautions
For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result from the use or derivation of this product.
Disease
Infectious diseases, Nephrology
Protocol
Protocol Sandwich ELISA
49 kb
Protocol Immuno Fluorescence
39 kb
Protocol IHC-P
43 kb
Protocol Flow Cytometry
58 kb
Protocol IHC-F
36 kb
CoA-TDS
HM2167F-20UG
107 kb
HM2167F-100UG
107 kb

Calculate your ELISA data easily

With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.